GROSSI, FEDERICA
GROSSI, FEDERICA
Dipartimento di Psicologia Generale - DPG
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)
2020 Gelsomino, F.; Lamberti, G.; Tiseo, M.; Rocco, D.; Pasello, G.; Cecere, F. L.; Chella, A.; Grilli, G.; Mandruzzato, M.; Tognetto, M.; Garassino, M. C.; Macerelli, M.; Novello, S.; Roila, F.; Colantonio, I.; Grossi, F.; Fiorentino, M.; Ardizzoni, A.
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial
2021 Camerini, A.; Morabito, A.; Montanino, A.; Bernabe, R.; Grossi, F.; Ramlau, R.; Ciuleanu, T. -E.; Ceresoli, G. -L.; Pasello, G.; de Marinis, F.; Bosch-Barrera, J.; Laundreau, P.; Gautier, S.; Ta Thanh Minh, C.; Kowalski, D.
Mutational profile of malignant pleural mesothelioma (MPM) in the phase II RAMES study
2020 Pagano, M.; Ceresoli, L. G.; Zucali, P. A.; Pasello, G.; Garassino, M.; Grosso, F.; Tiseo, M.; Parra, H. S.; Zanelli, F.; Cappuzzo, F.; Grossi, F.; De Marinis, F.; Pedrazzoli, P.; Gnoni, R.; Bonelli, C.; Torricelli, F.; Ciarrocchi, A.; Normanno, N.; Pinto, C.
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects
2018 Spallarossa, P.; Meliota, G.; Brunelli, C.; Arboscello, E.; Ameri, P.; Dessalvi, C. C.; Grossi, F.; Deidda, M.; Mele, D.; Sarocchi, M.; Bellodi, A.; Madonna, R.; Mercuro, G.